Aclarion Inc

Echo Lake Capital offers $4.00/share for Aclarion Inc. (NASDAQ: ACON) amid board governance concerns. Aclarion defends its MRS tech, AI platform, and upside potential from a reverse takeover. Discover the proposal’s details and the company’s growth …

Discover how Aclarion’s patented AI platform, Nociscan, transforms chronic low back pain care with 97% surgical success, cloud‑scalability, and industry awards.

Explore Aclarion Inc.’s 2026 Chairman’s shareholder letter—inside its AI‑driven MRS tech, micro‑cap status, and why the market hasn’t yet caught up.